These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9269866)

  • 21. Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose.
    Shen J; Wanwimolruk S; Purves RD; McQueen EG; Roberts MS
    J Pharmacokinet Biopharm; 1991 Oct; 19(5):575-95. PubMed ID: 1783992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of dose dependent kinetics of methyl salicylate-2-O-β-D-lactoside in rhesus monkeys after oral administration.
    He Y; Yan Y; Zhang T; Ma Y; Zhang W; Wu P; Song J; Wang S; Du G
    J Ethnopharmacol; 2015 Apr; 164():293-300. PubMed ID: 25571846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma salicylate from methyl salicylate cream compared to oil of wintergreen.
    Wolowich WR; Hadley CM; Kelley MT; Walson PD; Casavant MJ
    J Toxicol Clin Toxicol; 2003; 41(4):355-8. PubMed ID: 12870876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-dependent competitive block by topical acetylsalicylic and salicylic acid of low pH-induced cutaneous pain.
    Steen KH; Reeh PW; Kreysel HW
    Pain; 1996 Jan; 64(1):71-82. PubMed ID: 8867248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphatic transport of salicylates in dogs.
    Sudo LS; Almeida MG; Yasaka W; Garcia-Leme J
    Gen Pharmacol; 1989; 20(6):779-83. PubMed ID: 2591706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol.
    Brantmark B; Wåhlin-Boll E; Melander A
    Eur J Clin Pharmacol; 1982; 22(4):309-14. PubMed ID: 7106166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris.
    Kircik LH; Dahl A; Yatskayer M; Raab S; Oresajo C
    J Drugs Dermatol; 2012 Jun; 11(6):737-40. PubMed ID: 22648221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous absorption of salicylates from some commercially available topical products containing methyl salicylate or salicylate salts in rats.
    Megwa SA; Benson HA; Roberts MS
    J Pharm Pharmacol; 1995 Nov; 47(11):891-6. PubMed ID: 8708981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous absorption, disposition, and exposure assessment of homosalate, a UV filtering agent, in rats.
    Kim TH; Shin BS; Kim KB; Shin SW; Seok SH; Kim MK; Kim EJ; Kim D; Kim MG; Park ES; Kim JY; Yoo SD
    J Toxicol Environ Health A; 2014; 77(4):202-13. PubMed ID: 24555679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal reproductive effects of oral salicylic acid in Sprague-Dawley rats.
    Davis DP; Daston GP; Odio MR; York RG; Kraus AL
    Toxicol Lett; 1996 Mar; 84(3):135-41. PubMed ID: 8600612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of aspirin after therapeutic and toxic doses.
    Patel DK; Hesse A; Ogunbona A; Notarianni LJ; Bennett PN
    Hum Exp Toxicol; 1990 May; 9(3):131-6. PubMed ID: 2375880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement, analysis and prediction of topical UV filter bioavailability.
    Roussel L; Gilbert E; Salmon D; Serre C; Gabard B; Haftek M; Maibach HI; Pirot F
    Int J Pharm; 2015 Jan; 478(2):804-10. PubMed ID: 25526673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A kinetic-based safety assessment of consumer exposure to salicylic acid from cosmetic products demonstrates no evidence of a health risk from developmental toxicity.
    Labib R; Bury D; Boisleve F; Eichenbaum G; Girard S; Naciff J; Leal M; Wong J
    Regul Toxicol Pharmacol; 2018 Apr; 94():245-251. PubMed ID: 29410076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of repeated skin application on percutaneous absorption of salicylic acid.
    Roberts MS; Harlock E
    J Pharm Sci; 1978 Dec; 67(12):1685-7. PubMed ID: 722480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of chloroxylenol 0.5% plus salicylic acid 2% cream and benzoyl peroxide 5% gel in the treatment of acne vulgaris: a randomized double-blind study.
    Boutli F; Zioga M; Koussidou T; Ioannides D; Mourellou O
    Drugs Exp Clin Res; 2003; 29(3):101-5. PubMed ID: 14708455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris.
    Akarsu S; Fetil E; Yücel F; Gül E; Güneş AT
    J Dermatol; 2012 May; 39(5):433-8. PubMed ID: 22035285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dermatopharmacokinetics of salicylate following topical injection in rats: effect of osmotic pressure and injection volume on salicylate disposition.
    Yoshida D; Todo H; Hasegawa T; Sugibayashi K
    Int J Pharm; 2007 Jun; 337(1-2):142-7. PubMed ID: 17280809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative bioavailability of rapidly dispersing, plain, and microencapsuled acetylsalicylic acid tablets after single dose administration.
    Siegmund W; Hoffmann C; Zschiesche M; Steinijans VW; Sauter R; Krüger WD; Diedrich F
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):133-8. PubMed ID: 9562228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic availability of acetylsalicylic acid in human subjects after oral ingestion of three different formulations.
    Petersen T; Husted SE; Pedersen AK; Geday E
    Acta Pharmacol Toxicol (Copenh); 1982 Oct; 51(4):285-91. PubMed ID: 7180498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.